Breast cancer research : BCR
HSP90AA1-VDAC1 interaction contributes to breast cancer progression and doxorubicin resistance through PI3K/AKT signaling.
Yutong Fang, Cuiping Guo, Fengtao Zheng, Yefeng Xiao, Junpeng Liu, Yongqu Zhang, Jundong Wu
Published: 202610.1186/s13058-026-02225-8
No abstract available for this study.